Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Mol Genet Metab ; 121(2): 70-79, 2017 06.
Artículo en Inglés | MEDLINE | ID: mdl-28501294

RESUMEN

The design and conduct of clinical studies to evaluate the effects of novel therapies on central nervous system manifestations in children with neuronopathic mucopolysaccharidoses is challenging. Owing to the rarity of these disorders, multinational studies are often needed to recruit enough patients to provide meaningful data and statistical power. This can make the consistent collection of reliable data across study sites difficult. To address these challenges, an International MPS Consensus Conference for Cognitive Endpoints was convened to discuss approaches for evaluating cognitive and adaptive function in patients with mucopolysaccharidoses. The goal was to develop a consensus on best practice for the design and conduct of clinical studies investigating novel therapies for these conditions, with particular focus on the most appropriate outcome measures for cognitive function and adaptive behavior. The outcomes from the consensus panel discussion are reported here.


Asunto(s)
Cognición , Mucopolisacaridosis/terapia , Sistema Nervioso Central/fisiopatología , Niño , Ensayos Clínicos como Asunto , Determinación de Punto Final , Humanos , Mucopolisacaridosis/fisiopatología , Mucopolisacaridosis I/fisiopatología , Mucopolisacaridosis I/terapia , Mucopolisacaridosis II/fisiopatología , Mucopolisacaridosis II/terapia , Mucopolisacaridosis III/fisiopatología , Mucopolisacaridosis III/terapia , Enfermedades del Sistema Nervioso/terapia , Modalidades de Fisioterapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...